Association between genetic polymorphisms in DEFB1 and susceptibility to digestive diseases

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 2240-2250

  Huang, Yin Peng ^a   Wang, Tian Yi ^a   Wang, Wei ^a   Sun, Hong Zhi ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Digestive system abnormalities; Disease susceptibility; Meta analysis; Polymorphism, genetic

Indexed keywords

ACUTE PANCREATITIS; ALLELE; ARTICLE; CHRONIC GASTRITIS; CROHN DISEASE; DEFB1 GENE; DISEASE PREDISPOSITION; GASTROINTESTINAL DISEASE; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INFLAMMATORY BOWEL DISEASE; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; ADULT; CASE CONTROL STUDY; DIGESTIVE SYSTEM DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED;

BETA DEFENSIN; DEFB1 PROTEIN, HUMAN;

ADULT; BETA-DEFENSINS; CASE-CONTROL STUDIES; DIGESTIVE SYSTEM DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84938634754     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893453     Document Type: Article

References (40)

1. Thelen K, Coboeken K, Willmann S et al: Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions. J Pharm Sci, 2011; 100: 5324–45
2. Zhao Y, Chen Z, Ma Y et al: Lack of association between methionine synthase A2756G polymorphism and digestive system cancer risk: evidence from 3,9327 subjects. PLoS One, 2013; 8: e61511
3. Jemal A, Bray F, Center MM et al: Global cancer statistics. Cancer J Clin, 2011; 61: 69–90
4. Sung JJ, Ng EK, Lin JT et al: Digestive cancer management in Asia: position statements: a report on GI Oncology Summit in 2011. J Gastroenterol Hepatol, 2012; 27: 1417–22
5. Kocsis AK, Kiss ZF, Tiszlavicz L et al: Potential role of human beta-defensin 1 in Helicobacter pylori-induced gastritis. Scand J Gastroenterol, 2009; 44: 289–95
6. Nechuta S, Shu XO, Li HL et al: Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women’s Health Study. Am J Clin Nutr, 2012; 96: 1056–63
7. Hunter P: The secret garden. The human digestive system is teeming with microbiotic life, but just how important are these interlopers for health and disease? EMBO Rep, 2009; 10: 1082–86
8. Li P, Lv H, Yang H et al: IRF5, but not TLR4, DEFB1, or VDR, is associated with the risk of ulcerative colitis in a Han Chinese population. Scand J Gastroenterol, 2013; 48: 1145–51
9. Zanin V, Segat L, Bianco AM et al: DEFB1 gene 5’ untranslated region (UTR) polymorphisms in inflammatory bowel diseases. Clinics (Sao Paulo), 2012; 67: 395–98
10. Wilson TJ, Jobim M, Segat L et al: DEFB1 gene 5’ untranslated region (UTR) polymorphisms are marginally involved in inflammatory bowel disease in south Brazilians. Int J Immunogenet, 2014; 41: 138–42
11. Heapy AM, Williams GM, Fraser JD et al: Synthesis of a dicarba analogue of human beta-defensin-1 using a combined ring closing metathesis – native chemical ligation strategy. Org Lett, 2012; 14: 878–81
12. Taylor K, Barran PE, Dorin JR: Structure-activity relationships in beta-defensin peptides. Biopolymers, 2008; 90: 1–7
13. Harder J, Glaser R, Schroder JM: Human antimicrobial proteins effectors of innate immunity. J Endotoxin Res, 2007; 13: 317–38
14. Aerts AM, Francois IE, Cammue BP et al: The mode of antifungal action of plant, insect and human defensins. Cell Mol Life Sci, 2008; 65: 2069–79
15. Liu L, Zhao C, Heng HH et al: The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics, 1997; 43: 316–20
16. Milanese M, Segat L, Crovella S: Transcriptional effect of DEFB1 gene 5’ untranslated region polymorphisms. Cancer Res, 2007; 67: 5997; author reply 5997
17. Sun CQ, Arnold R, Fernandez-Golarz C et al: Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res, 2006; 66: 8542–49
18. Kallsen K, Andresen E, Heine H: Histone deacetylase (HDAC) 1 controls the expression of beta defensin 1 in human lung epithelial cells. PLoS One, 2012; 7: e50000
19. Andresen E, Gunther G, Bullwinkel J et al: Increased expression of betadefensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One, 2011; 6: e21898
20. Laube DM, Yim S, Ryan LK et al: Antimicrobial peptides in the airway. Curr Top Microbiol Immunol, 2006; 306: 153–82
21. Park SK, Yang JJ, Oh S et al: Innate immunity and non-Hodgkin’s lymphoma (NHL) related genes in a nested case-control study for gastric cancer risk. PLoS One, 2012; 7: e45274
22. Jackson D, White IR, Riley RD: Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med, 2012; 31: 3805–20
23. Jackson D, White IR, Riley RD: Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med, 2012; 31: 3805–20
24. Yang H, Li J, Tang R, et al: Telomere reverse transcriptase (TERT) rs2735940 increases cancer risk. Med Sci Monit, 2015; 21: 612–16
25. Peters JL, Sutton AJ, Jones DR et al: Comparison of two methods to detect publication bias in meta-analysis. JAMA, 2006; 295: 676–80
26. Xu X, Liang X, Hu G, et al: Renal function and klotho gene polymorphisms among Uygur and Kazak populations in Xinjiang, China. Med Sci Monit, 2015; 21: 44–51
27. Zintzaras E, Ioannidis JP: HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics, 2005; 21: 3672–73
28. Wang X, Lu X, Fang Y, et al: Association between miR34b/c polymorphism rs4938723 and cancer risk: a meta-analysis of 11 studies including 6169 cases and 6337 controls. Med Sci Monit, 2014; 20: 1977–82
29. Kocsis AK, Lakatos PL, Somogyvari F et al: Association of beta-defensin 1 single nucleotide polymorphisms with Crohn’s disease. Scand J Gastroenterol, 2008; 43: 299–307
30. Tiszlavicz Z, Szabolcs A, Takacs T et al: Polymorphisms of beta defensins are associated with the risk of severe acute pancreatitis. Pancreatology, 2010; 10: 483–90
31. Wang XF, Cao RM, Li J et al: Identification of sociodemographic and clinical factors associated with the levels of human beta-defensin-1 and human betadefensin- 2 in the human milk of Han Chinese. Br J Nutr, 2014; 111: 867–74
32. Bogefors J, Kvarnhammar AM, Hockerfelt U et al: Reduced tonsillar expression of human beta-defensin 1, 2 and 3 in allergic rhinitis. FEMS Immunol Med Microbiol, 2012; 65: 431–38
33. Carter JG, West SK, Painter S et al: beta-Defensin 1 haplotype associated with postoperative endophthalmitis. Acta Ophthalmol, 2010; 88: 786–90
34. Chen QX, Lv C, Huang LX et al: Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population. Genes Immun, 2007; 8: 439–43
35. Joly S, Compton LM, Pujol C et al: Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol, 2009; 24: 353–60
36. Casalicchio G, Freato N, Maestri I et al: Beta defensin-1 gene polymorphisms and susceptibility to atypical squamous cells of undetermined significance lesions in Italian gynecological patients. J Med Virol, 2014; 86: 1999–2004
37. Segat L, Morgutti M, Athanasakis E et al: Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy. Int J Immunogenet, 2010; 37: 169–75
38. Liu X, Li Z, Zhang Z, et al: Meta-analysis of GSTM1 null genotype and lung cancer risk in Asians. Med Sci Monit, 2014; 20: 1239–45
39. Yang M, Zhao J, Xing L, et al: Association between GSTM1 null genotype and coronary artery disease risk: a meta-analysis. Med Sci Monit, 2014; 20: 1550–55
40. Liu Z, Li P, Wang J, et al: A meta-analysis of IL-13 polymorphisms and pediatric asthma risk. Med Sci Monit, 2014; 20: 2617–23